Post Marketing Surveillance (PMS) of JARDIANCE in Chronic Heart Failure (CHF)

Post Marketing Surveillance on Long Term Drug Use of JARDIANCE® Tablets in Patients With Chronic Heart Failure in Japan

Study objective is to investigate the safety and effectiveness of long-term daily use of JARDIANCE® Tablets in patients with chronic heart failure (CHF) under real-world use.

Inclusion Criteria:

• Patients with chronic heart failure (CHF) failure who are prescribed with JARDIANCE® Tablets in Japan
• Patients who have never been treated with Empagliflozin (including treatment for type 2 diabetes mellitus (T2DM)) before enrolment

Exclusion Criteria:

• None